Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Engrailed protects mouse midbrain dopaminergic neurons against mitochondrial complex I insults.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 9809671 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-1726 (Electronic) Linking ISSN: 10976256 NLM ISO Abbreviation: Nat Neurosci Subsets: MEDLINE
    • بيانات النشر:
      Publication: <2002->: New York, NY : Nature Publishing Group
      Original Publication: New York, NY : Nature America Inc., c1998-
    • الموضوع:
    • نبذة مختصرة :
      Mice heterozygous for the homeobox gene Engrailed-1 (En1) display progressive loss of mesencephalic dopaminergic (mDA) neurons. We report that exogenous Engrailed-1 and Engrailed-2 (collectively Engrailed) protect mDA neurons from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a mitochondrial complex I toxin used to model Parkinson's disease in animals. Engrailed enhances the translation of nuclearly encoded mRNAs for two key complex I subunits, Ndufs1 and Ndufs3, and increases complex I activity. Accordingly, in vivo protection against MPTP by Engrailed is antagonized by Ndufs1 small interfering RNA. An association between Engrailed and complex I is further confirmed by the reduced expression of Ndufs1 and Ndufs3 in the substantia nigra pars compacta of En1 heterozygous mice. Engrailed also confers in vivo protection against 6-hydroxydopamine and α-synuclein-A30P. Finally, the unilateral infusion of Engrailed into the midbrain increases striatal dopamine content, resulting in contralateral amphetamine-induced turning. Therefore, Engrailed is both a survival factor for adult mDA neurons and a regulator of their physiological activity.
      (© 2011 Nature America, Inc. All rights reserved.)
    • Comments:
      Comment in: Nat Neurosci. 2011 Sep 27;14(10):1221-2. doi: 10.1038/nn.2939. (PMID: 21952262)
    • References:
      J Clin Invest. 2011 Mar;121(3):930-40. (PMID: 21393861)
      Lancet Neurol. 2008 Jan;7(1):97-109. (PMID: 18093566)
      Nature. 2005 Nov 3;438(7064):94-8. (PMID: 16267555)
      J Med Genet. 2004 Jan;41(1):14-7. (PMID: 14729820)
      Mol Cell Neurosci. 2007 Jun;35(2):230-6. (PMID: 17399993)
      Brain. 2010 Jul;133(Pt 7):2022-31. (PMID: 20573704)
      Neuron. 2003 Sep 11;39(6):889-909. (PMID: 12971891)
      FEBS Lett. 2011 Jun 6;585(11):1573-8. (PMID: 21565195)
      Science. 2003 Oct 31;302(5646):819-22. (PMID: 14593166)
      Cell. 2004 Jun 11;117(6):773-86. (PMID: 15186778)
      Mol Cell Biol. 2005 Feb;25(3):1100-12. (PMID: 15657436)
      J Neurosci. 2004 Jun 30;24(26):5922-30. (PMID: 15229240)
      Development. 2006 Sep;133(18):3499-506. (PMID: 16899537)
      Neurobiol Aging. 2011 Feb;32(2):302-7. (PMID: 19345444)
      Nat Rev Neurosci. 2006 Mar;7(3):207-19. (PMID: 16495942)
      J Neurosci. 2009 Dec 16;29(50):15923-32. (PMID: 20016108)
      J Neurosci. 2011 Apr 6;31(14):5495-503. (PMID: 21471386)
      Development. 2004 Jul;131(13):3229-36. (PMID: 15175251)
      Nature. 1988 Jul 28;334(6180):345-8. (PMID: 2899295)
      Nat Rev Neurosci. 2008 Oct;9(10):741-5. (PMID: 18769444)
      Science. 1995 Aug 4;269(5224):679-82. (PMID: 7624797)
      Curr Opin Neurobiol. 2006 Feb;16(1):59-66. (PMID: 16417998)
      Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10815-20. (PMID: 15247416)
      Science. 2009 Feb 6;323(5915):793-7. (PMID: 19131594)
      Nat Cell Biol. 2004 Mar;6(3):189-96. (PMID: 15039791)
      Brain Res. 1986 Oct 1;384(1):84-93. (PMID: 3791002)
      Neural Dev. 2008 May 28;3:13. (PMID: 18507846)
      J Neurochem. 2003 Feb;84(3):491-502. (PMID: 12558969)
      Neuron. 2009 Nov 12;64(3):355-366. (PMID: 19914184)
      J Biol Chem. 2008 Dec 12;283(50):34753-61. (PMID: 18826940)
      Hum Mol Genet. 2007 Jun 1;16(11):1319-26. (PMID: 17409193)
      J Biol Chem. 2006 Apr 14;281(15):10374-80. (PMID: 16478720)
      Genes Dev. 2009 Jan 1;23(1):1-11. (PMID: 19136621)
      Neurobiol Dis. 2008 Apr;30(1):8-18. (PMID: 18313315)
      Nat Rev Mol Cell Biol. 2003 Oct;4(10):814-9. (PMID: 14570063)
      J Neurochem. 2001 Jul;78(1):163-74. (PMID: 11432983)
      EMBO Rep. 2002 Feb;3(2):159-64. (PMID: 11818335)
      Histol Histopathol. 2005 Oct;20(4):1275-84. (PMID: 16136508)
      Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1325-30. (PMID: 17227870)
      Behav Brain Res. 2005 Jul 1;162(1):1-10. (PMID: 15922062)
      Nat Neurosci. 2010 Dec;13(12):1481-8. (PMID: 21057506)
      Annu Rev Neurosci. 2008;31:151-73. (PMID: 18558852)
      Trends Cell Biol. 2007 Oct;17(10):502-10. (PMID: 17804238)
      Neurobiol Aging. 2009 May;30(5):731-8. (PMID: 17905480)
      J Neurosci. 2007 Jan 31;27(5):1063-71. (PMID: 17267560)
      J Neurosci Methods. 2006 Nov 15;158(1):30-6. (PMID: 16797717)
      Exp Neurol. 2008 Mar;210(1):182-93. (PMID: 18053987)
      J Neurosci. 1985 Aug;5(8):2240-53. (PMID: 2991484)
      Neuroscience. 1997 Apr;77(4):1037-48. (PMID: 9130785)
    • الرقم المعرف:
      0 (Dopamine Plasma Membrane Transport Proteins)
      0 (Electron Transport Chain Complex Proteins)
      0 (En1 protein, mouse)
      0 (Homeodomain Proteins)
      0 (Nerve Tissue Proteins)
      0 (Neurotoxins)
      0 (Nitro Compounds)
      0 (Propionates)
      0 (RNA, Small Interfering)
      0 (alpha-Synuclein)
      0 (engrailed 2 protein)
      03L9OT429T (Rotenone)
      6LR8C1B66Q (Dizocilpine Maleate)
      8HW4YBZ748 (Oxidopamine)
      EC 1.14.16.2 (Tyrosine 3-Monooxygenase)
      EC 1.6.99.3 (NADH Dehydrogenase)
      QY4L0FOX0D (3-nitropropionic acid)
      VTD58H1Z2X (Dopamine)
    • الموضوع:
      Date Created: 20110906 Date Completed: 20111115 Latest Revision: 20211020
    • الموضوع:
      20250114
    • الرقم المعرف:
      10.1038/nn.2916
    • الرقم المعرف:
      21892157